DRUG Insider Trading Activity and SEC Form 4 Filings
DRUG insider trading summary
Over the past 12 months, insiders at Bright Minds Biosciences Inc. (DRUG) reported 3 sales worth $29.4M by 3 insiders and no open-market purchases on SEC Form 4. Net insider selling was $29.4M.
Latest DRUG insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 28, 2026 | Bihua Chen | Insider | Sell | $9.8M (109,331 @ $89.50) |
| Apr 28, 2026 | Cormorant Global Healthcare Master Fund, LP | Insider | Sell | $9.8M (109,331 @ $89.50) |
| Apr 28, 2026 | Cormorant Asset Management, LP | Insider | Sell | $9.8M (109,331 @ $89.50) |
| Nov 4, 2024 | Cormorant Asset Management, LP | Insider | Buy | $4.0M (184,331 @ $21.70) |
| Nov 4, 2024 | Bihua Chen | Insider | Buy | $4.0M (184,331 @ $21.70) |
| Oct 16, 2024 | Cormorant Asset Management, LP | Insider | Buy | $78K (3,107 @ $25.22) |
| Oct 16, 2024 | Bihua Chen | Insider | Buy | $78K (3,107 @ $25.22) |
| Oct 16, 2024 | Cormorant Global Healthcare Master Fund, LP | Insider | Buy | $923K (39,743 @ $23.21) |
| Oct 16, 2024 | Cormorant Asset Management, LP | Insider | Buy | $172K (7,150 @ $24.03) |
| Oct 16, 2024 | Bihua Chen | Insider | Buy | $923K (39,743 @ $23.21) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.